Microbial influences in inflammatory bowel diseases.

The predominantly anaerobic microbiota of the distal ileum and colon contain an extraordinarily complex variety of metabolically active bacteria and fungi that intimately interact with the host's epithelial cells and mucosal immune system. Crohn's disease, ulcerative colitis, and pouchitis are the result of continuous microbial antigenic stimulation of pathogenic immune responses as a consequence of host genetic defects in mucosal barrier function, innate bacterial killing, or immunoregulation. Altered microbial composition and function in inflammatory bowel diseases result in increased immune stimulation, epithelial dysfunction, or enhanced mucosal permeability. Although traditional pathogens probably are not responsible for these disorders, increased virulence of commensal bacterial species, particularly Escherichia coli, enhance their mucosal attachment, invasion, and intracellular persistence, thereby stimulating pathogenic immune responses. Host genetic polymorphisms most likely interact with functional bacterial changes to stimulate aggressive immune responses that lead to chronic tissue injury. Identification of these host and microbial alterations in individual patients should lead to selective targeted interventions that correct underlying abnormalities and induce sustained and predictable therapeutic responses.

[1]  S. Kane,et al.  Higher Incidence of Abnormal Pap Smears in Women With Inflammatory Bowel Disease , 2008, The American Journal of Gastroenterology.

[2]  D. Huso,et al.  Enterotoxigenic Bacteroides fragilis: A potential instigator of colitis , 2007, Inflammatory bowel diseases.

[3]  C. Jobin,et al.  Dual‐association of gnotobiotic Il‐10−/− mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis , 2007, Inflammatory bowel diseases.

[4]  D. Hommes,et al.  Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. , 2007, Immunity.

[5]  T. Klaenhammer,et al.  Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[6]  H. Clevers,et al.  The Paneth Cell α-Defensin Deficiency of Ileal Crohn’s Disease Is Linked to Wnt/Tcf-41 , 2007, The Journal of Immunology.

[7]  C. Pothoulakis,et al.  Inflammation and apoptosis in Clostridium difficile enteritis is mediated by PGE2 up-regulation of Fas ligand. , 2007, Gastroenterology.

[8]  D. Haller,et al.  Bacteria‐ and host‐derived mechanisms to control intestinal epithelial cell homeostasis: Implications for chronic inflammation , 2007, Inflammatory bowel diseases.

[9]  Martin Wiedmann,et al.  Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum , 2007, The ISME Journal.

[10]  N. Pace,et al.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.

[11]  B. Finlay,et al.  Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. , 2007, Cell host & microbe.

[12]  H. Wexler,et al.  Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis. , 2007, Microbial pathogenesis.

[13]  P. Gerner-Smidt,et al.  Invasive Escherichia coli are a feature of Crohn's disease , 2007, Laboratory Investigation.

[14]  A. Sharafkhaneh,et al.  Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. , 2007, Immunity.

[15]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[16]  U. Göbel,et al.  Shift Towards Pro-inflammatory Intestinal Bacteria Aggravates Acute Murine Colitis via Toll-like Receptors 2 and 4 , 2007, PloS one.

[17]  K. Whelan,et al.  Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials , 2007, Proceedings of the Nutrition Society.

[18]  D. Kalman,et al.  TLR Signaling Mediated by MyD88 Is Required for a Protective Innate Immune Response by Neutrophils to Citrobacter rodentium1 , 2007, The Journal of Immunology.

[19]  J. Hugot,et al.  CARD15/NOD2 Is Required for Peyer's Patches Homeostasis in Mice , 2007, PloS one.

[20]  W. Selby,et al.  Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. , 2007, Gastroenterology.

[21]  D. Podolsky,et al.  TLRs in the Gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[22]  N. Barnich,et al.  CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. , 2007, The Journal of clinical investigation.

[23]  C. Jobin,et al.  Gnotobiotic IL-10−/−;NF-κBEGFP Mice Reveal the Critical Role of TLR/NF-κB Signaling in Commensal Bacteria-Induced Colitis1 , 2007, The Journal of Immunology.

[24]  S. Targan,et al.  Anti‐flagellin (CBir1) phenotypic and genetic Crohn's disease associations , 2007, Inflammatory bowel diseases.

[25]  C. Elson,et al.  CCFA Microbial–Host Interactions Workshop: Highlights and key observations , 2007, Inflammatory bowel diseases.

[26]  Judy H Cho,et al.  Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis , 2007, Nature Genetics.

[27]  S. Nuding,et al.  Reduced mucosal antimicrobial activity in Crohn’s disease of the colon , 2007, Gut.

[28]  A. Lobo,et al.  A case-control study of drinking water and dairy products in Crohn's Disease--further investigation of the possible role of Mycobacterium avium paratuberculosis. , 2007, American journal of epidemiology.

[29]  A. Gruber,et al.  Epithelial-cell-intrinsic IKK-β expression regulates intestinal immune homeostasis , 2007, Nature.

[30]  M. Neurath,et al.  Epithelial NEMO links innate immunity to chronic intestinal inflammation , 2007, Nature.

[31]  Nathalie Rolhion,et al.  OmpC and the σE regulatory pathway are involved in adhesion and invasion of the Crohn's disease‐associated Escherichia coli strain LF82 , 2007, Molecular microbiology.

[32]  Kimberly A. Reske,et al.  Incidence of Clostridium difficile infection in inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[33]  Dawn B. Beaulieu,et al.  Impact of Clostridium difficile on inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[34]  F. Shanahan,et al.  Probiotic effects on inflammatory bowel disease. , 2007, The Journal of nutrition.

[35]  P. Mannon,et al.  The fundamental basis of inflammatory bowel disease. , 2007, The Journal of clinical investigation.

[36]  F. Cominelli,et al.  Commensal Bacteria Exacerbate Intestinal Inflammation but Are Not Essential for the Development of Murine Ileitis1 , 2007, The Journal of Immunology.

[37]  H. Ogata,et al.  Cytomegalovirus Is Frequently Reactivated and Disappears Without Antiviral Agents in Ulcerative Colitis Patients , 2007, The American Journal of Gastroenterology.

[38]  S. Targan,et al.  NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives. , 2007, Gastroenterology.

[39]  E. Vicaut,et al.  Risk Factors for Intra-Abdominal Septic Complications After a First Ileocecal Resection for Crohn’s Disease: A Multivariate Analysis in 161 Consecutive Patients , 2007, Diseases of the colon and rectum.

[40]  S. Brant,et al.  Testing the Interaction between NOD-2 Status and Serological Response to Mycobacterium paratuberculosis in Cases of Inflammatory Bowel Disease , 2007, Journal of Clinical Microbiology.

[41]  D. Relman,et al.  The role of microbes in Crohn's disease. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  I. Wilson,et al.  Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. , 2007, Journal of proteome research.

[43]  J. Korzenik Is Crohn’s disease due to defective immunity? , 2006, Gut.

[44]  U Wahnschaffe,et al.  Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease , 2006, Gut.

[45]  N. Barnich,et al.  Adherent-invasive Escherichia coli and Crohn's disease , 2007, Current opinion in gastroenterology.

[46]  J. Doré,et al.  Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis , 2006, Gut.

[47]  A. Ebringer,et al.  A possible link between Crohn’s disease and ankylosing spondylitis via Klebsiella infections , 2007, Clinical Rheumatology.

[48]  Thomas Lengauer,et al.  A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 , 2007, Nature Genetics.

[49]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[50]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[51]  J. Garcia-Gil,et al.  Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction‐denaturing gradient gel electrophoresis , 2006, Inflammatory bowel diseases.

[52]  S. Targan,et al.  Antibodies to I2 predict clinical response to fecal diversion in Crohn's disease , 2006, Inflammatory bowel diseases.

[53]  S. Cucchiara,et al.  Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease , 2006, Gut.

[54]  M. Gazouli,et al.  Relationship between Crohn's disease, infection with Mycobacterium avium subspecies paratuberculosis and SLC11A1 gene polymorphisms in Sardinian patients. , 2006, World journal of gastroenterology.

[55]  Yu-Tseung Liu,et al.  Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells , 2006, Nature Cell Biology.

[56]  J. Goldblum,et al.  Clostridium Difficile-Associated Pouchitis , 2006, Digestive Diseases and Sciences.

[57]  M. Kleerebezem,et al.  Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase , 2006, Inflammatory Bowel Diseases.

[58]  Shadi Sepehri,et al.  High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease , 2006, Gut.

[59]  J. Sillanpää,et al.  Endocarditis and biofilm-associated pili of Enterococcus faecalis. , 2006, The Journal of clinical investigation.

[60]  M. Behr,et al.  Mycobacteria in Crohn's disease: a persistent hypothesis. , 2006, Inflammatory bowel diseases.

[61]  H. Steinhart,et al.  Antibiotic therapy for Crohn's disease: a review. , 2006, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[62]  F. Shanahan,et al.  Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease , 2006, Journal of Clinical Microbiology.

[63]  U. Gophna,et al.  Differences between Tissue-Associated Intestinal Microfloras of Patients with Crohn's Disease and Ulcerative Colitis , 2006, Journal of Clinical Microbiology.

[64]  Bernhard Radlwimmer,et al.  A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. , 2006, American journal of human genetics.

[65]  R. Xu,et al.  Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. , 2006, Gastroenterology.

[66]  G. Gazelle,et al.  Risks and benefits of infliximab for the treatment of Crohn's disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[67]  F. Powrie,et al.  Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation , 2006, Immunological reviews.

[68]  R. Bibiloni,et al.  The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. , 2006, Journal of medical microbiology.

[69]  J. Harel,et al.  Adherent and Invasive Escherichia coli Is Associated with Granulomatous Colitis in Boxer Dogs , 2006, Infection and Immunity.

[70]  D. Haller,et al.  IL‐10 Gene‐Deficient Mice Lack TGF‐Beta/Smad‐Mediated TLR2 Degradation and Fail to Inhibit Proinflammatory Gene Expression in Intestinal Epithelial Cells under Conditions of Chronic Inflammation , 2006, Annals of the New York Academy of Sciences.

[71]  J. Meijerink,et al.  Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. , 2006, Gastroenterology.

[72]  R. Sartor Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[73]  M. Pop,et al.  Metagenomic Analysis of the Human Distal Gut Microbiome , 2006, Science.

[74]  Erik Remaut,et al.  A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[75]  A. Baldwin,et al.  Wound‐induced p38MAPK‐dependent histone H3 phosphorylation correlates with increased COX‐2 expression in enterocytes , 2006, Journal of cellular physiology.

[76]  J. Mallet,et al.  Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. , 2006, Gastroenterology.

[77]  A. Rahbar,et al.  Detection of cytotoxic CD13-specific autoantibodies in sera from patients with ulcerative colitis and Crohn's disease , 2006, Journal of Autoimmunity.

[78]  J. Valentine,et al.  Inhibition of phagosome maturation and survival of Mycobacterium avium subspecies paratuberculosis in polymorphonuclear leukocytes from Crohn's disease patients. , 2006, Medical science monitor : international medical journal of experimental and clinical research.

[79]  S. Targan,et al.  Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease. , 2006, Gastroenterology.

[80]  S. Deventer,et al.  Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study , 2006, Alimentary pharmacology & therapeutics.

[81]  Klaus Ley,et al.  The primary defect in experimental ileitis originates from a nonhematopoietic source , 2006, The Journal of experimental medicine.

[82]  J. Galanko,et al.  T cell‐mediated oral tolerance is intact in germ‐free mice , 2006, Clinical and experimental immunology.

[83]  M. Camilleri,et al.  Recommendations for probiotic use. , 2006, Journal of clinical gastroenterology.

[84]  K. Rioux,et al.  Probiotics in the treatment of inflammatory bowel disease. , 2006, Journal of clinical gastroenterology.

[85]  William D. Lees,et al.  Defective acute inflammation in Crohn's disease: a clinical investigation , 2006, The Lancet.

[86]  R. Ley,et al.  Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine , 2006, Cell.

[87]  C. Manichanh,et al.  Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.

[88]  Dennis Christie,et al.  Serum Immune Responses Predict Rapid Disease Progression among Children with Crohn's Disease: Immune Responses Predict Disease Progression , 2006, The American Journal of Gastroenterology.

[89]  P. Rutgeerts,et al.  Toll‐like receptor‐1, ‐2, and ‐6 polymorphisms influence disease extension in inflammatory bowel diseases , 2006, Inflammatory bowel diseases.

[90]  N. Rao,et al.  Abundant and Diverse Fungal Microbiota in the Murine Intestine , 2006, Applied and Environmental Microbiology.

[91]  H. Nagawa,et al.  Cytomegalovirus infection in ulcerative colitis , 2006, Scandinavian journal of gastroenterology.

[92]  C. Hawkey,et al.  Probiotics for maintenance of remission in Crohn's disease. , 2006, The Cochrane database of systematic reviews.

[93]  A. Forbes,et al.  Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease? , 2003, Gastroenterology.

[94]  Tatsuo Yamamoto,et al.  Change in the bacterial flora of pouchitis. , 2006, Hepato-gastroenterology.

[95]  Tomohiro Watanabe,et al.  Signalling pathways and molecular interactions of NOD1 and NOD2 , 2006, Nature Reviews Immunology.

[96]  A. Gewirtz,et al.  Flagellin/TLR5 responses in epithelia reveal intertwined activation of inflammatory and apoptotic pathways. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[97]  M. Weichenthal,et al.  Reduced Paneth cell α-defensins in ileal Crohn's disease , 2005 .

[98]  C. Ackerley,et al.  Epitope shared by functional variant of organic cation/carnitine transporter, OCTN1, Campylobacter jejuni and Mycobacterium paratuberculosis may underlie susceptibility to Crohn's disease at 5q31. , 2005, Biochemical and biophysical research communications.

[99]  M. Gottfried,et al.  Piroxicam Treatment of Il‐10‐Deficient Mice Enhances Colonic Epithelial Apoptosis and Mucosal Exposure to Intestinal Bacteria , 2005, Inflammatory bowel diseases.

[100]  J. Sundberg,et al.  Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens. , 2005, Gastroenterology.

[101]  H. Redmond,et al.  A characterization of anaerobic colonization and associated mucosal adaptations in the undiseased ileal pouch , 2005, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[102]  M. Gazouli,et al.  Mycobacterium avium subsp. paratuberculosis, Genetic Susceptibility to Crohn's Disease, and Sardinians: the Way Ahead , 2005, Journal of Clinical Microbiology.

[103]  Ping-Chang Yang,et al.  Rhinosinusitis derived Staphylococcal enterotoxin B possibly associates with pathogenesis of ulcerative colitis , 2005, BMC gastroenterology.

[104]  S. Akira,et al.  Macrophage migration inhibitory factor contributes to the development of acute dextran sulphate sodium‐induced colitis in Toll‐like receptor 4 knockout mice , 2005, Clinical and experimental immunology.

[105]  R. Balicer,et al.  Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease , 2005, Gut.

[106]  M. Zeitz,et al.  Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. , 2005, Gastroenterology.

[107]  S. Targan,et al.  Defects in mucosal immunity leading to ulcerative colitis , 2005, Immunological reviews.

[108]  P. Rutgeerts,et al.  Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. , 2005, The New England journal of medicine.

[109]  H. Lochs,et al.  Spatial Organization and Composition of the Mucosal Flora in Patients with Inflammatory Bowel Disease , 2005, Journal of Clinical Microbiology.

[110]  R. Bibiloni,et al.  Analysis of the large bowel microbiota of colitic mice using PCR/DGGE , 2005, Letters in applied microbiology.

[111]  T. Giese,et al.  High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn’s disease , 2005, Gut.

[112]  G. Rogler,et al.  Glycoprotein (gp) 96 expression: induced during differentiation of intestinal macrophages but impaired in Crohn’s disease , 2005, Gut.

[113]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[114]  R. Sartor,et al.  Does Mycobacterium avium subspecies paratuberculosis cause Crohn’s disease? , 2005, Gut.

[115]  S. Targan,et al.  Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. , 2005, Gastroenterology.

[116]  W. Schmiegel,et al.  Association between the promoter polymorphism T/C at position -159 of the CD14 gene and anti-inflammatory therapy in patients with inflammatory bowel disease. , 2005, European journal of medical research.

[117]  R. Xu,et al.  Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[118]  P. Rutgeerts,et al.  Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. , 2005, Gastroenterology.

[119]  R. Sartor,et al.  Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. , 2005, Gastroenterology.

[120]  N. Barnich,et al.  Strong Decrease in Invasive Ability and Outer Membrane Vesicle Release in Crohn's Disease-Associated Adherent-Invasive Escherichia coli Strain LF82 with the yfgL Gene Deleted , 2005, Journal of bacteriology.

[121]  L. Eckmann,et al.  Amendment history : Corrigendum ( April 2005 ) Toll-like receptor 9 – induced type I IFN protects mice from experimental colitis , 2018 .

[122]  H. Lochs,et al.  Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. , 2005, World journal of gastroenterology.

[123]  Richard A. Flavell,et al.  Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract , 2005, Science.

[124]  H. Drummond,et al.  Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. , 2005, Gastroenterology.

[125]  C. Jobin,et al.  STAT3 regulates NF-κB recruitment to the IL-12p40 promoter in dendritic cells , 2005 .

[126]  J. Orenstein,et al.  Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. , 2005, The Journal of clinical investigation.

[127]  T. Ohkusa,et al.  Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: A randomized, controlled pilot trial with long-term follow-up , 2005, Scandinavian journal of gastroenterology.

[128]  T. Giese,et al.  Expression of Interleukin‐12‐Related Cytokine Transcripts in Inflammatory Bowel Disease: Elevated Interleukin‐23p19 and Interleukin‐27p28 in Crohn's Disease But Not in Ulcerative Colitis , 2005, Inflammatory bowel diseases.

[129]  R. Chiodini,et al.  Possible role of mycobacteria in inflammatory bowel disease , 1984, Digestive Diseases and Sciences.

[130]  T. Hirayama,et al.  This information is current as Signaling in Intestinal Epithelial Cells-Defensin-2 Expression Is Regulated by TLR β and , 2004 .

[131]  M. Stolte,et al.  Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine , 2004, Gut.

[132]  Laurent Beaugerie,et al.  High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.

[133]  Tomohiro Watanabe,et al.  NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses , 2004, Nature Immunology.

[134]  F. Shanahan,et al.  Bacterial DNA within Granulomas of Patients with Crohn's Disease—Detection by Laser Capture Microdissection and PCR , 2004, American Journal of Gastroenterology.

[135]  G. Greenberg,et al.  High-Level Serum Antibodies to Bacterial Antigens Are Associated with Antibiotic-Induced Clinical Remission in Crohn's Disease: A Pilot Study , 2004, Digestive Diseases and Sciences.

[136]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[137]  L. Mayer,et al.  Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. , 2004, Gastroenterology.

[138]  S. Targan,et al.  Bacterial flagellin is a dominant antigen in Crohn disease , 2004 .

[139]  W. Harmsen,et al.  Early Postoperative Complications are not Increased in Patients with Crohn's Disease Treated Perioperatively with Infliximab or Immunosuppressive Therapy , 2004, American Journal of Gastroenterology.

[140]  R Balfour Sartor,et al.  Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. , 2004, Gastroenterology.

[141]  M. Karin,et al.  IκB-kinaseβ-dependent NF-κB activation provides radioprotection to the intestinal epithelium , 2004 .

[142]  W. Mow,et al.  Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. , 2004, Gastroenterology.

[143]  F. Seibold,et al.  pANCA Represents a Cross-Reactivity to Enteric Bacterial Antigens , 1998, Journal of Clinical Immunology.

[144]  R. Sartor,et al.  Mechanisms of acute and chronic intestinal inflammation induced by indomethacin , 1993, Inflammation.

[145]  A. Zinsmeister,et al.  The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. , 2004, Gastroenterology.

[146]  S. Pettersson,et al.  Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA , 2004, Nature Immunology.

[147]  H. Harmsen,et al.  Antibiotics with a selective aerobic or anaerobic spectrum have different therapeutic activities in various regions of the colon in interleukin 10 gene deficient mice , 2003, Gut.

[148]  M. Neurath,et al.  Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. , 2003, The Journal of clinical investigation.

[149]  S. Davies,et al.  Crohn's disease and the NOD2 gene: a role for paneth cells. , 2003, Gastroenterology.

[150]  R. Schwabe,et al.  Transforming Growth Factor- (cid:1) 1 Inhibits Non-pathogenic Gram-negative Bacteria-induced NF- (cid:2) B Recruitment to the Interleukin-6 Gene Promoter in Intestinal Epithelial Cells through Modulation of Histone Acetylation* , 2022 .

[151]  D. Podolsky,et al.  CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. , 2003, Gastroenterology.

[152]  C. Elson,et al.  Bacterial-Reactive T Regulatory Cells Inhibit Pathogenic Immune Responses to the Enteric Flora1 , 2002, The Journal of Immunology.

[153]  C. Neut,et al.  Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease , 2002, American Journal of Gastroenterology.

[154]  Mark M Huycke,et al.  Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. , 2002, Carcinogenesis.

[155]  H. Buhr,et al.  Mucosal and Invading Bacteria in Patients with Inflammatory Bowel Disease Compared with Controls , 2002, Scandinavian journal of gastroenterology.

[156]  Manfred Dietel,et al.  Mucosal flora in inflammatory bowel disease. , 2002, Gastroenterology.

[157]  S. Kitajima,et al.  Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice. , 2001, Experimental animals.

[158]  Sinead B. O'Leary,et al.  Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease , 2001, Nature Genetics.

[159]  Jean-Frederic Colombel,et al.  Adherent Invasive Escherichia coli Strains from Patients with Crohn's Disease Survive and Replicate within Macrophages without Inducing Host Cell Death , 2001, Infection and Immunity.

[160]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[161]  Judy H. Cho,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[162]  J. Gordon,et al.  Commensal Host-Bacterial Relationships in the Gut , 2001, Science.

[163]  J. Schölmerich,et al.  Different Subsets of Enteric Bacteria Induce and Perpetuate Experimental Colitis in Rats and Mice , 2001, Infection and Immunity.

[164]  R. Sartor,et al.  Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(epsilon26) mice. , 2001, Gastroenterology.

[165]  J. Boudeau,et al.  Type 1 pili‐mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells , 2001, Molecular microbiology.

[166]  J. Gordon,et al.  Molecular analysis of commensal host-microbial relationships in the intestine. , 2001, Science.

[167]  A. Young,et al.  Prokaryotic Regulation of Epithelial Responses by Inhibition of IκB-α Ubiquitination , 2000 .

[168]  W. Fiers,et al.  Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. , 2000, Science.

[169]  P. Brigidi,et al.  Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. , 2000, Gastroenterology.

[170]  S. Naser,et al.  Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients , 2000, American Journal of Gastroenterology.

[171]  K. Madsen,et al.  Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. , 1999, Inflammatory bowel diseases.

[172]  V. Godfrey,et al.  IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[173]  K. Wilson,et al.  Differential Induction of Colitis and Gastritis in HLA-B27 Transgenic Rats Selectively Colonized with Bacteroides vulgatus or Escherichia coli , 1999, Infection and Immunity.

[174]  J. Cebra,et al.  Influences of microbiota on intestinal immune system development. , 1999, The American journal of clinical nutrition.

[175]  G. Kollias,et al.  Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. , 1999, Immunity.

[176]  N. Barnich,et al.  Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. , 1998, Gastroenterology.

[177]  J. C. Jones,et al.  A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. , 1998, Journal of immunology.

[178]  R. Sartor,et al.  Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice , 1998, Infection and Immunity.

[179]  J. Sundberg,et al.  CD4+ T Cells Reactive to Enteric Bacterial Antigens in Spontaneously Colitic C3H/HeJBir Mice: Increased T Helper Cell Type 1 Response and Ability to Transfer Disease , 1998, The Journal of experimental medicine.

[180]  F. Guarner,et al.  Stimulation of transforming growth factor beta1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis. , 1998, Gastroenterology.

[181]  P. Rutgeerts,et al.  Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. , 1998, Gastroenterology.

[182]  J. Macfie,et al.  Microbiology of bacterial translocation in humans , 1998, Gut.

[183]  M. Kagnoff,et al.  Epithelial cells as sensors for microbial infection. , 1997, The Journal of clinical investigation.

[184]  J. Sanderson,et al.  Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. , 1997, The Journal of antimicrobial chemotherapy.

[185]  M. Fishman,et al.  Impaired Defense of Intestinal Mucosa in Mice Lacking Intestinal Trefoil Factor , 1996, Science.

[186]  P. Katsel,et al.  On the etiology of Crohn disease. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[187]  J. Sanderson,et al.  IS900 PCR to detect Mycobacterium paratuberculosis in retail supplies of whole pasteurized cows' milk in England and Wales , 1996, Applied and environmental microbiology.

[188]  R. Hammer,et al.  Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. , 1996, The Journal of clinical investigation.

[189]  R. Hilsden,et al.  Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. , 1996, Gastroenterology.

[190]  I. Forgacs,et al.  Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. , 1996, Gut.

[191]  K. Ewe,et al.  Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) , 1995, Clinical and experimental immunology.

[192]  J. Gordon,et al.  Inflammatory Bowel Disease and Adenomas in Mice Expressing a Dominant Negative N-Cadherin , 1995, Science.

[193]  P. Rutgeerts,et al.  Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. , 1995, Gastroenterology.

[194]  A. West,et al.  Immunocytochemical evidence of Listeria, Escherichia coil, and Streptococcus antigens in Crohn's disease☆ , 1995, Gastroenterology.

[195]  C. Elson,et al.  Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. , 1994, Gastroenterology.

[196]  R. Hammer,et al.  The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats , 1994, The Journal of experimental medicine.

[197]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[198]  B. Rowlands,et al.  Colonic bacteria and bacterial translocation in experimental colitis , 1993, The British journal of surgery.

[199]  Van Kruiningen Hj,et al.  An immunocytochemical search for infectious agents in Crohn's disease. , 1993 .

[200]  W. Roediger,et al.  Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. , 1993, Gastroenterology.

[201]  R. Chiodini,et al.  Crohn's disease and the mycobacterioses: a review and comparison of two disease entities , 1989, Clinical Microbiology Reviews.

[202]  R. Sartor,et al.  Systemic uptake and intestinal inflammatory effects of luminal bacterial cell wall polymers in rats with acute colonic injury , 1988, Infection and immunity.

[203]  M. Broom,et al.  Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis. , 1988, Gastroenterology.

[204]  J. Rotter,et al.  Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. , 1986, Annals of internal medicine.

[205]  W. J. Cromartie,et al.  Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. , 1985, Gastroenterology.

[206]  M. Keighley,et al.  Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn's disease surgery , 1984, The British journal of surgery.

[207]  M. Keighley,et al.  Incidence and microbiology of abdominal and pelvic abscess in Crohn's disease. , 1982, Gastroenterology.

[208]  J. Mcghee,et al.  Lipopolysaccharide (LPS) regulation of the immune response: LPS converts germfree mice to sensitivity to oral tolerance induction. , 1982, Journal of immunology.

[209]  M. Kagnoff On the etiology of Crohn's disease. , 1978, Gastroenterology.